Which are the top companies operating in the biological safety testing industry?

Major companies, including bioM Read More

Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Biological Safety Testing Market

Biological Safety Testing Market Share

Report ID: GMI4278
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Biological Safety Testing Market Share

The biological safety testing industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Biological Safety Testing Market Companies

Some of the eminent market participants operating in the biological safety testing industry include:

bioMérieux S.A.
Charles River Laboratories International, Inc.
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Lonza Group Ltd
Merck KGaA
Samsung Biologics
Sartorius AG
SGS Societe Generale de Surveillance SA
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Biological safety testing industry size was USD 4.1 billion in 2023 and will record a 13.6% CAGR between 2024 and 2032, attributed to the increasing focus on drug safety and quality control within the pharmaceutical and biotechnology industries.

The reagents and kits segment in the biological safety testing industry will reach USD 4.9 billion by 2032, owing to the pivotal role these components play in conducting a wide range of tests, from cell-based assays to endotoxin detection.

North America biological safety testing industry secured 1.7 billion in 2023, primarily due to the region's advanced healthcare infrastructure, stringent regulatory requirements, and significant investments in the biotechnology and pharmaceutical industries.

Major companies, including bioM